Related Experiment Video
Updated: Mar 6, 2026

Murine Dermal Fibroblast Isolation by FACS
Published on: January 7, 2016
Dendritic Cell-Associated MARCKSL1 Regulates Fibroblast Differentiation During Wound Healing
Kento Takaya1, Yukari Nakajima1, Shigeki Sakai1
1Department of Plastic and Reconstructive Surgery, Keio University School of Medicine, Tokyo, Japan.
Myristoylated alanine-rich C-kinase substrate-like 1 (MARCKSL1) in dendritic cells drives scar formation by promoting fibroblast activity. Inhibiting MARCKSL1 in dendritic cells significantly reduces scarring, offering a potential therapeutic target for wound healing.
Area of Science:
- Regenerative Medicine
- Immunology
- Dermatology
Background:
- Immune cells, particularly dendritic cells, are crucial in wound healing and scar formation.
- Dendritic cells' role extends beyond antigen presentation to modulating fibrotic processes.
- Identifying specific molecular pathways in dendritic cells involved in scarring is key for therapeutic development.
Purpose of the Study:
- To investigate the role of myristoylated alanine-rich C-kinase substrate-like 1 (MARCKSL1) in dendritic cells during wound healing and scar formation.
- To determine if MARCKSL1 expression in dendritic cells influences fibroblast activity.
- To evaluate the therapeutic potential of targeting MARCKSL1 in dendritic cells for scar prevention.
Main Methods:
- Single-cell RNA sequencing of murine scar tissue to identify MARCKSL1 expression in dendritic cells.
- Utilizing a mouse fetal wound healing model to observe MARCKSL1-positive dendritic cell accumulation.
- Stimulating mouse dendritic cells with transforming growth factor beta 1 (TGF-β1) and co-culturing with fibroblasts.
- Employing MARCKSL1 shRNA to knockdown expression in dendritic cells and MANS peptide as an inhibitor in vivo.
Main Results:
- MARCKSL1 was identified in dendritic cell clusters within fibrotic regions of murine scars.
- MARCKSL1-positive dendritic cells accumulated at wound margins during scar formation.
- TGF-β1 stimulation enhanced MARCKSL1 expression in dendritic cells, promoting fibroblast to myofibroblast differentiation.
- MARCKSL1 knockdown in dendritic cells diminished this pro-fibrotic effect.
- Inhibition of MARCKSL1 with MANS peptide significantly reduced scar formation in mice.
Conclusions:
- MARCKSL1 expression in dendritic cells plays a significant role in modulating fibroblast activity and promoting fibrotic responses during wound healing.
- Targeting MARCKSL1 in dendritic cells represents a promising therapeutic strategy for preventing excessive scarring and promoting regenerative wound healing.
More Related Videos
Related Concept Videos
Introduction to Fibroblasts
Role of Matrix Metalloproteases in Degradation of ECM
Phases of Wound Repair
Formation of Blood Clot
In case of deep injuries, trauma to blood vessels results in blood loss. In the meantime, phospholipids released from the ruptured endothelial cellular membrane are converted into arachidonic...
Cell Migration
The Extracellular Matrix
In order to maintain tissue organization, many animal cells are surrounded by structural molecules that make up the extracellular matrix (ECM). Together, the molecules in the ECM maintain the structural integrity of tissue as well as the remarkable specific properties of certain tissues.
Composition of the Extracellular Matrix
The extracellular matrix (ECM) is commonly composed of ground substance, a gel-like fluid, fibrous components, and many structurally and functionally diverse...
TGF - β Signaling Pathway

